114 related articles for article (PubMed ID: 3044104)
1. Respiratory complications of cardiac transplantation.
Schulman LL; Smith CR; Drusin R; Rose EA; Enson Y; Reemtsma K
Am J Med Sci; 1988 Jul; 296(1):1-10. PubMed ID: 3044104
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus pneumonitis after cardiac transplantation.
Schulman LL; Reison DS; Austin JH; Rose EA
Arch Intern Med; 1991 Jun; 151(6):1118-24. PubMed ID: 1645949
[TBL] [Abstract][Full Text] [Related]
3. Early infections in kidney, heart, and liver transplant recipients on cyclosporine.
Dummer JS; Hardy A; Poorsattar A; Ho M
Transplantation; 1983 Sep; 36(3):259-67. PubMed ID: 6310832
[TBL] [Abstract][Full Text] [Related]
4. Infectious complications with the use of cyclosporine versus azathioprine after cadaveric kidney transplantation.
Shaffer D; Hammer SM; Monaco AP
Am J Surg; 1987 Apr; 153(4):381-6. PubMed ID: 3105340
[TBL] [Abstract][Full Text] [Related]
5. Effect of treatment with cyclosporine versus azathioprine on incidence and severity of cytomegalovirus infection posttransplantation.
Bia MJ; Andiman W; Gaudio K; Kliger A; Siegel N; Smith D; Flye W
Transplantation; 1985 Dec; 40(6):610-4. PubMed ID: 3000031
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of cyclosporine compared with azathioprine in cadaveric renal transplantation.
Henry ML; Sommer BG; Ferguson RM
Am J Surg; 1985 Nov; 150(5):533-6. PubMed ID: 2998215
[TBL] [Abstract][Full Text] [Related]
7. Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients.
Greenberg A; Egel JW; Thompson ME; Hardesty RL; Griffith BP; Bahnson HT; Bernstein RL; Hastillo A; Hess ML; Puschett JB
Am J Kidney Dis; 1987 Jan; 9(1):12-22. PubMed ID: 3544821
[TBL] [Abstract][Full Text] [Related]
8. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA
J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
[TBL] [Abstract][Full Text] [Related]
10. Cardiac transplant patient at one year. Cyclosporine vs conventional immunosuppression.
Emery RW; Cork R; Christensen R; Levinson MM; Icenogle TB; Riley J; Ott RA; Copeland JG
Chest; 1986 Jul; 90(1):29-33. PubMed ID: 3522120
[TBL] [Abstract][Full Text] [Related]
11. Control of cytomegalovirus disease in renal transplant patients treated with prednisone, azathioprine and cyclosporine using intensive monitoring and decreased immunosuppression.
Gómez E; de Oña M; Mélon S; Alvarez R; Laures A; Rodríguez M; Pobes A; Alvarez-Grande J
Nephron; 1999; 82(3):238-45. PubMed ID: 10395996
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.
Gao SZ; Schroeder JS; Alderman EL; Hunt SA; Valantine HA; Wiederhold V; Stinson EB
Circulation; 1989 Nov; 80(5 Pt 2):III100-5. PubMed ID: 2805287
[TBL] [Abstract][Full Text] [Related]
13. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE
J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
[TBL] [Abstract][Full Text] [Related]
15. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids.
Hofflin JM; Potasman I; Baldwin JC; Oyer PE; Stinson EB; Remington JS
Ann Intern Med; 1987 Feb; 106(2):209-16. PubMed ID: 3541723
[TBL] [Abstract][Full Text] [Related]
16. Increased incidence of cholelithiasis in heart transplant recipients receiving cyclosporine therapy.
Spes CH; Angermann CE; Beyer RW; Schreiner J; Lehnert P; Kemkes BM; Theisen K
J Heart Transplant; 1990; 9(4):404-7. PubMed ID: 2398436
[TBL] [Abstract][Full Text] [Related]
17. [Infectious diseases in kidney transplant recipients treated with cyclosporin].
Takahashi K; Yagisawa T; Hiroshi T; Teraoka S; Fuchinoue S; Honda H; Goya N; Tanabe K; Ebihara K; Ooba S
Nihon Hinyokika Gakkai Zasshi; 1989 Feb; 80(2):175-84. PubMed ID: 2664294
[TBL] [Abstract][Full Text] [Related]
18. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
